Medical Xpress: Researchers identify new target to treat pediatric brain tumors

UC's Timothy Phoenix part of team researching pediatric diffuse midline gliomas

Researchers have identified the role of a key gene that helps a type of pediatric brain tumor to grow, which could help develop better treatments.

Diffuse midline gliomas, formerly referred to as Diffuse Intrinsic Pontine Gliomas (DIPG), are tumors of the primary central nervous system, meaning they begin in the brain or spinal cord. Each year, approximately 200-300 children in the United States are diagnosed with this tumor that is commonly located in the brain stem, with a nearly zero percent survival rate. 

Recent research published by the University of Cincinnati's Timothy Phoenix, PhD, assistant professor in UC’s James L. Winkle College of Pharmacy Division of Pharmaceutical Sciences and a UC Cancer Center member, as well as colleagues from the Dana-Farber Cancer Insitute, Broad Institute of MIT and Harvard and others, focused on a gene called PPM1D.

The researchers found PPM1D is a gene that helps promote the growth of the tumors and that drugs could potentially target this gene to treat patients. In animal models of the tumors, the tumor cells died when the gene was disabled.

Read the Medical Xpress article.

Read more about Dr. Phoenix's research into diffuse midline gliomas.

Featured photo at top of Dr. Phoenix: Photo/Colleen Kelley/UC Creative + Brand

Related Stories


WVXU: Health benefits and risks to recreational marijuana

December 1, 2023

The University of Cincinnati's LaTrice Montgomery joined WVXU's Cincinnati Edition to discuss the potential health benefits and harms associated with expanded cannabis access after Ohio voters approved legalizing recreational marijuana in the November election.


Local 12: New research could help treat cocaine use disorder by...

December 1, 2023

New research out of the University of Cincinnati takes a different approach to cocaine addiction. Local 12 produced a story on the study, interviewing lead researcher Andrew Norman, PhD, of the Department of Pharmacology and Systems Physiology at the UC College of Medicine.


Clean Earth Rovers cofounders named to Forbes 30 Under 30 list

November 30, 2023

A pair of graduates of the University of Cincinnati’s Venture Lab program were recognized as being among the top entrepreneurs in North America as part of the 2024 Forbes 30 Under 30 list. Clean Earth Rovers cofounders Michael Arens and David Constantine were named to the 13th annual Forbes 30 Under 30 list in the energy category.

Debug Query for this